Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours

Summary

The primary objective of the study was to identify the maximum tolerated dose and to evaluate safety, pharmacokinetics, pharmacodynamic parameters, and efficacy of BIBW 2992.

Timeline

Start

2004-11

Primary completion

2007-03

Completion

—

Drugs

Indications